SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study

Background: In a previous pilot weight-loss study, an association was observed between baseline fasting plasma glucose (FPG) levels and the effectiveness of the Gelesis100 treatment. The aim of this subanalysis of the Gelesis Loss Of Weight (GLOW; NCT02307279) study is to further assess the associat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Greenway, Frank, Fujioka, Ken, Aronne, Louis, Raben, Anne, Astrup, Arne, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Apovian, Caroline, Hill, James, Kaplan, Lee, Navas-Carretero, Santiago, Martinez, J., Still, Christopher, Sannino, Alessandro, Saponaro, Cosimo, Calderon, Henry, Urban, Lorien, Chiquette, Elaine, Leider, Harry, Ron, Eyal, Zohar, Yishai, Heshmati, Hassan
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2019
Assuntos:
Adipose Tissue, Appetite, and Obesity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552254/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados